In a groundbreaking/revolutionary/significant development in the fight against cancer, a novel/innovative/cutting-edge treatment is showing remarkable/promising/encouraging results in clinical trials. The therapy, developed by researchers/scientists/a team of medical experts at renowned institution/leading university/prestigious research center, ut

Pharmaceutical labs commit significant capital to acquiring cutting-edge equipment. However, these sophisticated instruments often sit unused, resulting in a significant financial burden. Underutilized equipment represents a loss ofinvestment and can negatively affect a lab's productivity. Quantifying the magnitude of this financial consequence is